Research Review The strength of the genetic overlap between ADHD and other psychiatric symptoms – a systematic review and meta-analysis
Andersson A, Tuvblad C, Chen Q, Du Rietz E, Cortese S, Kuja-Halkola R, Larsson H.
J Child Psychol Psychiatry. 2020 Mar 10.
Commentary* by Dr. Margaret Weiss: The genetics of ADHD continues to unfold. We often inform our patients that “ADHD is 80% heritable”, although only 22% of that is explained by actual genetic loci. In this study we find further confirmation that genetic risk seems to predict mental illness in general, rather than supporting our diagnostic differentiation between psychiatric conditions.
Background: Attention-deficit/hyperactivity disorder (ADHD) frequently co-occurs with other psychiatric disorders. Twin studies have established that these co-occurrences are in part due to shared genetic risks. However, the strength of these genetic overlaps and the potential heterogeneity accounted for by type of psychiatric symptoms, age, and methods of assessment remain unclear. We conducted a systematic review to fill this gap.
Methods: We searched PubMed, PsycINFO, Embase, and Web of Science until March 07, 2019. Genetic correlations (rg ) were used as effect size measures.
Results: A total of 31 independent studies fulfilled the inclusion criteria. The pooled estimates showed that the associations between ADHD and other psychiatric symptoms were partly explained by shared genetic factors, with a pooled genetic correlation of 0.50, 95% confidence interval: 0.46-0.60. The genetic correlations (rg ) between ADHD and externalizing (rg = .49 [0.37-0.61]), internalizing (rg = .50 [0.39-0.69]), and neurodevelopmental (rg = .56 [0.47-0.66]) symptoms were similar in magnitude. The genetic correlations in childhood and adulthood were rg = .53 (0.43-0.63) and rg = .51 (0.44-0.56), respectively. For methods of assessment, the genetic correlations were also similar in strength, self-reports rg = .52 (0.47-0.58), other informants rg = .55 (0.41-0.69), and combined raters rg = .50 (0.33-0.65).
Conclusions: These findings indicate that the co-occurrence of externalizing, internalizing, and neurodevelopmental disorder symptoms in individuals with ADHD symptoms in part is due to a shared genetic risk.
* Les résumés scientifiques (abstracts) sont sélectionnés pour leur pertinence clinique par Dre. Margaret Weiss, Directrice de la recherche clinique, pédopsychiatrie, Cambridge Health Alliance, Université Harvard. Ses commentaires reflètent sa propre opinion. Ils ne sont ni approuvés par la CADDRA, ni nécessairement représentatifs de celle-ci.